Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (5)

« Back to Publications

lternative Payment Models for Innovative Medicines: A Framework for Effective Implementation

McElwee F. et al, (2025), Applied Health Economics and Health Policy

INVESTING IN OPTIMIZED HIV PREVENTION AMONG YOUNG MEN WHO HAVE SEX WITH MEN IN BRAZIL: INSIGHTS FROM FISCAL HEALTH MODELING

Danchenko N. et al, (2025), VALUE IN HEALTH, 28, S134 - S134

The Value of Flexible Vaccine Manufacturing Capacity: Value Drivers, Estimation Methods, and Approaches to Value Recognition in Health Technology Assessment.

McElwee F. and Newall A., (2024), Pharmacoeconomics, 42, 187 - 197

Federal Support Should Not Be A Factor In Determining Pharmaceutical Prices Under The IRA

McElwee F. et al, (2024), Health Affairs Forefront

HPR116 Is Payment Innovation Keeping Up With Therapy Innovation? A New Taxonomy of Innovative Payment Solutions to Aid Effective Implementation

McElwee F. et al, (2023), Value in Health, 26, S274 - S274